News

Article

Greenberger Explains Why Immunotherapy Will Be an Important Class of Therapies for Blood Cancers

Key Takeaways

  • Immunotherapy advancements in hematological cancers, especially Hodgkin lymphoma, show promising potential for treatment improvements.
  • The American Society of Hematology's annual meeting highlighted significant progress in blood cancer research.
SHOW MORE

Lee Greenberger, of the Leukemia & Lymphoma Society, explains how immunotherapy research has progressed in hematological cancers and the potential for these burgeoning therapies.

Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, explains how immunotherapy research has progressed in hematological cancers and the potential for these burgeoning therapies. The latest in blood cancer research, including studies involving immunotherapy for Hodgkin lymphoma, were announced at the annual meeting of the American Society of Hematology.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of melanoma
image of Kelsey Martin
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.